X
‘Trojan horse’ cancer drug shows promise in multiple tumour types
https://pharmaphorum.com/news/trojan-horse-cancer-drug-shows-promise-multiple-tumour-types/
Genmab
J&J rumoured to be sizing up $12bn Genmab acquisition
Speculation mounts that J&J will bid for R&D partner
Novartis’ Arzerra gains CLL approval
Development partner Genmab says drug approved in relapsed disease.